AC Immune SA ACIU 深 沪
等待开盘 08-15 09:30:00 美东时间
2.13
-0.070
-3.18%
华盛通- 最 高2.15
- 今 开2.15
- 成交量 9.48万股
- 最 低 2.09
- 昨 收 2.20
- 总市值 2.15亿
- 52周最高 3.98
- 市盈率 静 --
- 换手率 0.09%
- 52周最低 1.4299
- 委 比 -55.06%
- 总股本 1.01亿
- 历史最高 17.40
- 量 比 0.81
- 振 幅 2.73%
- 历史最低 1.4299
- 每 手 1
- 风险率 0.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多AC Immune Q2 EPS $(0.21) Misses $(0.17) Estimate, Sales $1.54M Miss $1.98M Estimate
AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 20.69 percent. This is a 16 percent increase over losses of $(0.25) per share from the same
08-05 19:25
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
AC Immune reported strong progress in its neurodegenerative disease pipeline and a solid cash position of CHF 127.1 million. The company highlighted advancements in three active immunotherapies, including ACI-7104.056 in Parkinson's disease, demonstrating strong immunogenicity and safety. The Phase 2 ABATE trial for ACI-24.060 in Alzheimer's disease is on track to reach its 12-month treatment timepoint by year-end. Additionally, the small molecul...
08-05 11:00
AC Immune SA Announces Leadership Changes in Development Team
An announcement from AC Immune SA ( ($ACIU) ) is now available. On June 11, 202...
06-12 04:27
'FDA Clears First Blood Test Used In Diagnosing Alzheimer's Disease; New Test Provides Less Invasive Option, Reduces Reliance On Pet Scans And Increases Diagnosis Accessibility' - FDA
https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease#:~:text=The%20Lumipulse%20G%20pTau217%2F%C3%9F,and%20symptoms%20of%20the%20disease.
05-17 01:32
Analysts’ Top Healthcare Picks: AC Immune SA (ACIU), Praxis Precision Medicines (PRAX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-05 19:10
AC Immune GAAP EPS of -CHF0.19
AC Immune press release (NASDAQ:ACIU): Q1 GAAP EPS of -CHF0.19. More on AC Immune AC Immune: Leader In Dementia Therapies, A Space Littered With Failures AC Immune updates data from mid-stage trial fo...
04-30 20:09
AC Immune’s Strategic Advances and Financial Highlights
AC Immune ( ($ACIU) ) has released its Q4 earnings. Here is a breakdown of the ...
04-03 11:51
AC Immune updates data from mid-stage trial for Parkinson’s candidate
AC Immune (NASDAQ:ACIU) added ~22% in the premarket on Wednesday after the Swiss biotech shared additional interim results from a mid-stage trial for ACI-7104.056, its experimental therapy targeted at...
04-02 18:52
美股大行评级 | Tigress Financial：维持爱彼迎"买入"评级，目标价从195美元升至200美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1107588488073326592.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持ProQR Therapeutics(PRQR)"买入"评级，目标价从10美元升至12美元</p> <p>• Oppenheimer：上调内克塔治疗(NKTR)评级至"跑
03-17 10:10
AC Immune reports FY results
AC Immune press release (NASDAQ:ACIU): FY GAAP EPS of -CHF0.51. Revenue of CHF27.31M (+84.5% Y/Y). Cash resources of CHF 165.5 million at year end provides funding into Q1 2027, assuming no other mile...
03-13 19:25
